Skip to main content
Premium Trial:

Request an Annual Quote

LSBC, U. of Arkansas for Medical Sciences to Produce Drug Abuse Antibody Treatment

NEW YORK, Feb. 28 -Large Scale Biology and the University of Arkansas for Medical Sciences in Little Rock, Ark., have announced an agreement to manufacture therapeutic antibodies to drugs of abuse, the company said today.


Under the agreement, LSBC will first produce an antibody target for the street drug phencyclidine, also known as "angel dust" and PCP.


Michael Owens, who is the director of UAMS; center for alcohol and drug abuse studies, chose LSBC for the production of the antibody. The contract will be financed by National Institute on Drug Abuse grants that fund Owens' research. Owens group has demonstrated through preclinical studies on animals that a monoclonal antibody has potential use for PCP abusers, according to LSBC.


For more information, see the company statement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.